Spironolactone
Term · Oncology and biomedicine · MLC-T-ONC-016846
A synthetic 17-spironolactone corticosteroid with potassium-sparing diuretic, antihypertensive, and antiandrogen activities.Spironolactone competitively inhibits adrenocortical hormone aldosterone activity in the distal renal tubules, myocardium, and vasculature. This agent may inhibit the pathophysiologic effects of aldosterone produced in excess by various types of malignant and benign tumors.
| Identifier | MLC-T-ONC-016846 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | SPL |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016846",
"term": "Spironolactone",
"field": "Oncology and biomedicine",
"definition": "A synthetic 17-spironolactone corticosteroid with potassium-sparing diuretic, antihypertensive, and antiandrogen activities.Spironolactone competitively inhibits adrenocortical hormone aldosterone activity in the distal renal tubules, myocardium, and vasculature. This agent may inhibit the pathophysiologic effects of aldosterone produced in excess by various types of malignant and benign tumors.",
"abbreviation": "SPL",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/spironolactone/"
}
Record 15,257 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.